GoKawiilScience Corporation's Prima retinal implant restores central vision in AMD patients
Science Corporation has developed the Prima system, a retinal implant paired with camera-equipped eyeglasses, to treat the central blind spot caused by advanced age-related macular degeneration. The device replaces lost photoreceptor cells and routes visual signals through remaining healthy retinal circuitry to the brain. It received approval in Europe in July and is still awaiting FDA clearance in the US, with over 80% of trained recipients reportedly able to read, do crosswords, and use phones afterward.
GoKawiil's interpretation of the reporting above, not reported fact.
AMD affects more than 5 million people worldwide and until now had no treatment capable of restoring vision, so a working implant could mark a significant shift for a condition previously managed only by slowing decline. The approach of leveraging intact retinal circuitry rather than fully replacing eye function suggests a broader strategy for treating other photoreceptor-loss conditions, according to the device's medical director. Its path to US approval will determine how quickly patients outside Europe can access it.
- Prima combines a retinal implant with camera glasses to treat central vision loss from AMD.
- It has EU approval and is awaiting FDA clearance in the US.
- Over 80% of trained recipients regained ability to read, do crosswords, and use phones.
Source: technologyreview.com — Linda Marsa, 2026-10-16
Published there as: “This implant can restore sight for patients with macular degeneration”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.